Repligen
RGEN
#1861
Rank
C$15.16 B
Marketcap
C$237.21
Share price
-2.75%
Change (1 day)
8.92%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2026 (TTM): C-$0.30

According to Repligen 's latest financial reports the company's current EPS (TTM) is C-$0.29. In 2025 the company made an earnings per share (EPS) of C$1.25 an increase over its 2024 EPS that were of C-$0.73.

EPS history for Repligen from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.30-124.31%
2025C$1.25-270.59%
2024C-$0.73-168%
2023C$1.07-77.68%
2022C$4.8143.59%
2021C$3.35105.26%
2020C$1.63153.33%
2019C$0.6418.42%
2018C$0.54-47.95%
2017C$1.05108.57%
2016C$0.5020.69%
2015C$0.4216%
2014C$0.36-48.98%
2013C$0.706.52%
2012C$0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02-455.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$27.20-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$12.50-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.47-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C-$0.54 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C-$2.18 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$9.98-3,585.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$1.68-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C-$0.13-55.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$1.46-610.00%๐Ÿ‡บ๐Ÿ‡ธ USA